Showing results (11-20 of 178) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Recognition of adult T-cell leukemia/lymphoma cells by CD4+ helper T lymphocytes specific for human T-cell leukemia virus type I envelope proteinHiroya Kobayashi, Toshihiro Nagato, Mitsuru Yanai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Recognition of prostate and breast tumor cells by helper T lymphocytes specific for a prostate and breast tumor-associated antigen, TARPHiroya Kobayashi, Toshihiro Nagato, Kensuke Oikawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytesHiroya Kobayashi, Toshihiro Ngato, Keisuke Sato, et al.
Cancer|June 2, 2007
Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction, Esteban Celis
Cancer Research|September 7, 2007
Toll-like receptor ligands energize peptide vaccines through multiple pathsEsteban Celis
Cancer Immunology, Immunotherapy : CII|October 23, 2008
Focal adhesion kinase as an immunotherapeutic targetHiroya Kobayashi, Makoto Azumi, Yuka Kimura, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2015
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphomaTakumi Kumai, Toshihiro Nagato, Hiroya Kobayashi, et al.
Cancer Research|February 5, 2008
Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cellsHiroya Kobayashi, Toshihiro Nagato, Miki Takahara, et al.
Oncoimmunology|May 8, 2015
c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphomaTakumi Kumai, Yoshinari Matsuda, Takayuki Ohkuri, et al.
Journal of Translational Medicine|November 8, 2011
Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancerSatoshi Hayashi, Takumi Kumai, Yoshiya Matsuda, et al.
Pageof 18